New Haven · Pre-Seed–Series A · 15 people tracked
Investment thesis
Elm Street Ventures invests at seed and early stage in companies built on great science and led by strong teams, with a focus on Yale-connected startups commercializing university research. It primarily targets companies whose technology was developed at and licensed from Yale, and also invests in the greater New Haven area, with occasional exceptions where the team has strong personal connections or can add substantial value. In evaluating deals, the firm weighs team strength — creativity, intelligence, passion, and commitment — as heavily as or more than the technology or market. Its focus areas include therapeutics, advanced industrial tools and materials, and climate interventions, aiming for great impact.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website
What they invest in
from 3 of 3 portfolio companiesBiotech ×2Climate Tech ×1Deep Tech ×1Digital Health ×1GovTech ×1Healthtech ×1SaaS ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro path
Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Paul Fonteyne(Co-Founder)Stephen Strittmatter(Scientific Founder)Stephen Bloch(CEO, Co-Founder)Timothy Siegert(COO, Co-Founder)Jennifer Gabler(Executive Officer)
BoardRobert A. Bettigole(Director)in
Co-investorsSpring Mountain CapitalConnecticut InnovationsWHIN
Elm Street Ventures is a seed and early-stage venture capital fund that invests in startups with a Yale University connection, typically commercializing research licensed from Yale, as well as companies in the greater New Haven area.
BiotechClimate TechDeep TechNew Haven, US
Co-investorsConnecticut InnovationsOmidyar Network
SeeClickFix 311 CRM by CivicPlus is a 311 platform that lets residents report local issues, request repairs, and send feedback or questions to their local government.
GovTechSaaSNew Haven, US
Charles Kampmann Lasater(Executive Officer, Director)Ben Berkowitz(Executive Officer, Director)Miles Lasater(Director)
BoardMark Jacobsen(Director)
Co-investorsLaunchCapitalConnecticut Innovations
Portfolio news
latest coverage across their companies
Allyx Therapeutics, Inc. · hartfordbusiness.com · Jun 15, 2026
Frequently asked questions
- What stage does Elm Street Ventures invest at?
- Elm Street Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Elm Street Ventures's typical check size?
- Elm Street Ventures typically writes checks of $250K – $1M.
- What sectors does Elm Street Ventures focus on?
- Elm Street Ventures focuses on Biotech, Cleantech, Climate Tech, Cloud Computing, Deep Tech, Digital Health, Healthtech, IoT, Medical Devices, New Materials, SaaS.
- Where is Elm Street Ventures located?
- Elm Street Ventures is headquartered in New Haven, US.
- Does Elm Street Ventures lead rounds?
- Yes, Elm Street Ventures leads investment rounds.
Media · Podcasts & interviews
featuring the teamRob Bettigole (Elm Street Ventures) - Seed and Early Stage Venture Capital
Startup Grind Local · Rob Bettigole
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
BSV Ventures runs an incubation and acceleration program and makes seed-stage investments in R&D-driven startups, with a focus on HealthTech, BioTech, and MedTech as well as deep-tech domains.
BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner, backing emerging and established fund managers who invest in technology-focused Canadian companies.
Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.
MPG Fund is an early-stage venture investor backing technology startups.